We have cloned and sequenced mouse cDNAs corresponding to a third member of a family of melanocytespecific mRNAs, which encode tyrosinase and related proteins. This new member, tyrosinase-related protein-2 (TRP-2), has -40% amino acid identity with the two other proteins in the family and has the same structural features including two copper binding sites, two cysteinerich regions, a signal peptide and a transmembrane domain. We now show that one of the cysteine-rich regions in this protein family is an 'EGF-like' repeat found in many extraceliular and cell surface proteins. The gene encoding TRP-2 maps to mouse chromosome 14, in the region of the coat colour mutation slaty. We show that the TRP-2 of slay mice has a single amino acid difference from wild-type TRP-2; a substitution of glutamine for arginine in the first copper binding site. TRP-2 is the much sought melanogenic enzyme DOPAchrome tautomerase (DT), which catalyses the conversion of DOPAchrome to 5,6,dihydroxyindole-2-carboxylic acid. Extracts from mice homozygous for the slaty mutation have a 3-fold or more reduction in DT activity, indicating that TRP-2/DT is encoded at the slaty locus, and the missense mutation reduces but does not abolish the enzyme activity.
Introduction
Mutations at numerous loci affecting mouse hair colour have been invaluable in dissecting the developmental processes leading to pigment production by melanocytes (Silvers, 1979; Jackson, 1985 Jackson, , 1991 . Several of these pigmentation genes have many mutant alleles, resulting from the specific locus mutation tests (Russell, 1951; Searle, 1974) . Recombinant cDNAs have been cloned from three of these six specific loci, namely dilute, albino and brown. The first of these encodes a novel myosin heavy chain protein, involved in melanocyte shape and pigment distribution (Mercer et al., 1991) . The other two encode proteins related to each other.
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The albino locus on mouse chromosome 7 encodes the enzyme tyrosinase (Muller et al., 1988; Kwon et al., 1989; Takeda et al., 1989; Yamamoto et al., 1989 ) a melanocytespecific enzyme which converts tyrosine to 3,4-dihydroxyphenylalanine (DOPA), DOPA to DOPAquinone and possibly also 5,6-dihydroxyindole to indole-5,6-quinone (Korner and Pawelek, 1982) . Deletions or point mutations in the tyrosinase gene give rise to loss or reduction of enzyme activity, and thus to complete or partial loss of all pigment Shibahara et al., 1990; Yokoyama et al., 1990) . Mice homozygous for the albino mutation can be restored to wild-type phenotype by transgenic insertion of the wild-type tyrosinase gene (Tanaka et al., 1990; Yokoyama et al., 1990) .
A protein with -36% amino acid identity to tyrosinase, termed tyrosinase-related protein-1 (TRP-1), was initially isolated as a candidate for tyrosinase (Shibahara et al., 1986) . Subsequent mapping and functional studies showed that TRP-I maps to the brown locus on chromosome 4 (Jackson, 1988; Muller et al., 1988) whereas tyrosinase is encoded by the albino locus on chromosome 7. At the brown locus deletions or null point mutations do not eliminate pigmentation, but result in mice with brown, instead of black eumelanin (Zdarsky et al., 1990) . Other mutations at this locus result in an intermediate phenotype, between black and brown, due to a reduction in the amount of TRP-1 mRNA, whilst still others have a dominant phenotype resulting in premature melanocyte death . Homozygous brown melanocytes in culture can be restored to wild-type pigmentation by the introduction of the wildtype TRP-1 sequence in a recombinant retrovirus .
A cDNA, termed 5A, was previously identified by screening of a melanocyte cDNA expression library with anti-tyrosinase antibodies (Jackson, 1988) . The clone shows some cross-hybridization with pMT4, a TRP-1 cDNA clone, but encodes a different protein, which we term TRP-2 (tyrosinase-related protein-2). We report here the sequence of TRP-2, which is homologous to TRP-1 and tyrosinase and retains many of the features common to these two proteins. Antibodies to the C-terminal portion of TRP-2 detect a protein in melanocytes and melanoma of both mouse and humans. The protein has DOPAchrome tautomerase (DT) activity (see Discussion and Tsukamoto et al., 1992) . Genetic mapping using an interspecific backcross indicates that the gene is unlinked to either previously described locus, and is located distally on chromosome 14 at or near to a pigmentation locus called slaty (slt). (Jackson, 1988 Figure 1 . The '-1,-3' rule of von Heijne (1986) predicts that cleavage of the signal sequence should take place between the alanine and glutamine residues where indicated. This position is equivalent to the putative signal peptide cleavage sites of tyrosinase and TRP-1. There are 15 cysteine residues in conserved positions between tyrosinase, TRP-1 and TRP-2. These are circled in Figure 1 . In addition TRP-2 has seven putative glycosylation sites of the form NXS or NXT. Of these, three are in conserved positions in both other family members and the other four are found in either tyrosinase or TRP-1. The C-terminal peptide used to raise antibodies is boxed. One, s, is a recessive spotting mutation, defective in melanocyte migration. Another, Rn, is a semi-dominant mutation which results in non-or partially pigmented hairs.
Mapping of
The third is slaty, a recessive mutation which uniformly affects the eumelanin, so that on a non-agouti background, (in which the hairs are pigmented only with eumelanin) the mice are a dark grey/brown colour rather than black . In view of the brown phenotype resulting from mutations of TRP-1, we took slaty to be the best candidate for a mutation of TRP-2.
Expression and sequence of the slaty TRP-2 mRNA
The slaty mutation arose spontaneously on a non-inbred background. We obtained mice from The Jackson Laboratory in which the mutation had been backcrossed onto the C57BL/6J background. We prepared RNA from the skin of 5 day old homozygous slaty mice. Northern blot hybridization, probed with the TRP-2 cDNA shows that the amount of TRP-2 mRNA in the slaty mice is the same as in the wild-type C57BL/6 (Figure 3a) .
We therefore used PCR to amplify the whole coding region of the TRP-2 cDNA made from the skin RNA, and purified the 1700 bp fragment by gel electrophoresis. Pairs of primers were used in PCR on the fragment to amplify overlapping 400-500 bp fragments of the cDNA which were sequenced directly with the priming oligonucleotides and with internal primers (see Materials and methods).
A single base pair difference only was found between the slaty TRP-2 coding region and the wild-type sequence in Figure 1 . This is a G to A transition at base 985 which results Tyrosinase-related protein-2 is the slaty gene product in a change in codon 194, changing the wild-type arginine in the dinucleotide CpG. This dinucleotide is the common residue to glutamine. Figure 3b shows by the deamination of the methyl-C resulting in a T:G pair which, on replication can result in the substitution of G by A. The mutation destroys a TaqI restriction site. To show that the mutation is present in slaty cDNA we used PCR to amplify a 320 bp segment of cDNA from slaty skin, from two wild-type skin cDNAs (C57BL/6 and BALB/c) and from the B16 melanoma cell line from which the TRP-2 cDNA was initially cloned. Figure 3c shows that the TaqI site is present in the wild-type strain cDNAs but is absent from the TRP-2 transcript of slaty mice.
Expression and function of wild-type and slaty TRP-2
Antibodies were raised in rabbits against a peptide (PEP8)
consisting of the C-terminal 14 amino acids of TRP-2 530 Figure 4A ). This size is larger than that predicted from the open reading frame in Figure 1 , and is accounted for by glycosylation of the primary translation product, in common with tyrosinase and TRP-1. A 55 000 molecular weight precursor polypeptide can also be detected. The recognition of these peptides by anti-PEP8 sera confirms that the open reading frame as shown is expressed. These proteins are also detectable in human MNT1 melanoma cells ( Figure 4A) . A thorough characterization of the aPEP8 serum is described in Tsukamoto et al. (1992) Extracts from the eyes of neonatal wild-type (C57BL6/J), albino (BALB/c) and slaty (congenic with C57BL/6J) mice were examined by Western blotting using the aPEP8 antibody to detect TRP-2. Eyes contain the retinal epithelium layer, which is made up of melanocytes, and therefore contain the melanogenic enzymes. The amount of TRP-2 immunoreactive protein detected in slaty mice is highly variable, sometimes being undetectable and at other times being close to the amount seen in wild-type eyes. Figure 4B is a Western blot, in which TRP-2 is visualized in extracts from the three strains, showing that the protein detected in slaty mice is the same size as wild-type. The protein precipitated by the cuPEP8 serum has DOPAchrome tautomerase (DT) activity (Tsukamoto et al., 1992) . DT is an enzyme, previously known as DOPAchrome conversion factor, DOPAchrome oxidoreductase or DOPAchrome isomerase Murray et al., 1983; Barber et al., 1984; Aroca et al., 1990; Pawelek, 1990) which participates in melanin synthesis by converting DOPAchrome to 5,6,-dihydroxyindole carboxylic acid (DHICA). It has until now been only partially characterized. We propose that TRP-2 is DT, and will refer to it hereafter as TRP-2/DT.
Eye extracts from the same three strains examined in Figure 4B were assayed for enzyme activity. Table I summarizes the tyrosinase and DT activity from the three strains. The DT activity in slaty eyes is somewhat variable, but is consistently lower than in wild-type or albino extracts and the mean is less than one-third wild-type. Furthermore, the extraction of enzyme activity appears to be influenced by the melanin synthesized. The melanogenic enzymes are localized within the melanosomes, where melanin is synthesized and deposited. The enzymes become coated with melanin during its synthesis, and therefore more difficult to extract. This is seen as a higher yield of DT from albino eyes (without melanin) than black eyes (with wild-type melanin), and a higher recovery of tyrosinase from the slaty eyes compared with wild-type. The tyrosinase difference cannot be due to differences other than near the slaty locus as the slaty mice and wild-type are congenic. We may therefore take tyrosinase activity as a measure of enzyme extraction efficiency, and hence the relative activity of DT in slaty compared with wild-type falls to < 10%. This correlation between the point mutation in the TRP-2/DT protein in slaty mice and the decrease in DT activity in the Table I same animals is a strong indication that the slaty locus does indeed encode TRP-2/DT.
Discussion
We have described here the identification of a third member of the tyrosinase protein family, TRP-2/DT. This appears to be an old family. The genes are dispersed and located on three different chromosomes, with no obvious chromosomal relationships. The overall amino acid identity between family members is of the order of 40%, which is scattered throughout the proteins. Figure 5 shows a comparison between the amino acid sequences of all three. Examination of silent base substitutions at codons for conserved amino acids suggests that the substitutions have reached saturation; that is, the genes have been evolving independently for a sufficiently long time that the only nucleic acid identity seen is that which is required for amino acid identity, and no relics remain of the ancestral gene. Further, when the gene structures of tyrosinase and TRP-1 are compared, their intron/exon organizations are quite different , again suggesting an ancient duplication. A clearer idea of the age of the gene triplication will be obtained by looking at the family in other species. We examined the amino acid sequence of TRP-2/DT using the programme Prosearch (L. F. Kowalski, MIT) to compare 531 with the Prosite database of motifs of Bairoch (1991) and to carry out a sequence comparison with the protein sequence database using the distributed array processor. We have found that the first cysteine-rich domain is a previously unreported member of the 'EGF-like' family. This widespread motif consists of a number of cysteines, aromatic residues, and glycines in a characteristically spaced pattern (reviewed by Davis, 1990) . Figure 6 shows Fig. 6 . Comparison of the tyrosinase-related protein EGF domain. Alignment of amino acid sequences of some of the proteins containing the EGF domain. The single-letter amino acid code is used, X = any amino acid residue, -= gap introduced to maximize alignment. The key conserved residues are enclosed by a box. References to all sequences can be found in Davis (1990) , except serrate, which is Fleming et al. (1990) and Thomas et al. (1991) .
clotting factors X and XI have two motifs, whilst others have many copies, over 30 in some cases. The best match to the TRP EGF domain is with the multiple repeats in the extracellular matrix proteins, laminins A, Bl and B2. The spacing of the conserved cysteines, in addition to conserved glycine and aromatic residues is identical between the TRPs and the laminin repeats. Other extracellular proteins such as tenascin, fibulin and entactin have repeats in which some of the spacings are slightly different from the TRPs, but nevertheless are clearly related. Also related are a number of Drosophila developmental gene products, such as Notch, Delta, crumbs, serrate and slit, and the nematode developmental genes lin-12 and glp.
The function of the EGF repeat is enigmatic. The pattern of disulphide bridges between cysteines, where it has been determined, is always 1-3, 2-4 and 5-6 (the first cysteine in Figure 6 is number 2). The two classic mouse mutations in tyrosinase (albino) and TRP-1 (brown) are substitutions of cysteines 5 and 4 respectively in this motif, and a recently characterized human albinism mutation has been found in cysteine 2 Zdarsky et al., 1990; Spritz et al., 1991) A common thread between the families which contain the EGF motif appears to be that all are extracellular proteins which may participate in protein-protein interaction. The TRPs are not extracellular, but rather are most likely bound to the inner (lumenal) face of the melanosome, the subcellular site of pigment synthesis. We propose that all three family members co-localize in the membrane, where they form a multi-enzyme complex which undertakes eumelanin synthesis. The EGF repeat is perhaps required for interaction between the proteins and the formation of the complex. In support of this notion Pawelek et al. (1991) have recently demonstrated that a high molecular weight complex can be isolated from melanosomes which contains tyrosinase, gp75 (human TRP-1) and DT (TRP-2). They have also demonstrated MSH-receptor function in this complex. It remains to be seen whether additional proteins participate.
The point mutation we identify is a strong candidate for the slaty mutation, and make it highly likely that TRP-2/DT is encoded at the slaty locus. Further genetic analysis of the locus is limited; the slaty mutation is the only mutant allele known. Nor is the background strain of origin of the mutation known. The arginine to glutamine mutation in the slaty TRP-2/DT is located in the first copper binding site of the protein. This amino acid residue is only moderately conserved between family members. The equivalent residue is also arginine in mouse TRP-1 and tyrosinase, and is the similarly basic amino acid lysine in human TRP-1, but in human tyrosinase the equivalent residue is methionine. To date, nine different missense mutations have been identified in human tyrosinase which produce type IA albinism (a complete loss of tyrosinase activity) Kikuchi et al., 1990; Spritz et al., 1990 Spritz et al., , 1991 Takeda et al., 1990; Oetting et al., 1991a,b) . All nine change amino acids which are identical across all five members of the tyrosinase-related family (two human and three mouse). In addition, the two loss-of-function cysteine mutations in mouse tyrosinase and TRP-1 are conserved across the whole family (Zdarsky et al., 1990; . By contrast, the two characterized mutations which lead to type IB (yellow) albinism, and which, like the TRP-2/DT slaty mutation do not give a complete loss-of-function, are in amino acid residues which, as in the slaty mutation, are only conserved across some of the family members (Giebel et al., 1991) .
Can the dark grey/brown phenotype of homozygous slaty mice be rationalized by the reduction of DT activity? In the absence of the enzyme DOPAchrome spontaneously converts to DHI. Ito (1986) has shown by acid degradation of melanins that melanins formed by tyrosinase alone in vitro contain -10% DHICA, the rest being mostly DHI. By contrast, analysis of natural melanins, from melanoma cells or from black hair, consists of at least 50% DHICA. We have shown (Tsukamoto et al., 1992 ) that little or no DHICA is made from DOPAchrome in vitro in the absence of DT, whether spontaneously or in the presence of tyrosinase alone. It seems likely that it is a difference in DHICA content which results in the different colours of wild-type (black) versus slaty eumelanin. The colour difference is a subtle one, which probably reflects the residual DT activity in slaty animals. It will be interesting to create null mutations of TRP-2/DT to observe their effects on pigmentation, and also to see if absence of DT activity has any other phenotypic effect on development. It is possible that complete lack of DT might have a severe effect on viability of melanocytes; DHI is quite a cytotoxic metabolite (Pawelek and Lerner, 1978; Pawelek et al., 1980) , while DHICA appears to be somewhat less toxic (unpublished) .
In summary, we have identified a novel tyrosinase-related protein, shown that it maps to and is mutated at the coat colour locus, slaty, and shown that the mutant protein is deficient for DOPAchrome tautomerase activity. The identification of the mutant will be invaluable for further studies of the protein's function, and for further dissection of the development of melanocyte function. 533
